Breast Cancer From screening to diagnosis to treatment, the experts in the Breast Evaluation and Treatment Service at the University of Maryland Marlene and Stewart.
Through expertise and cutting-edge technology, Stanford Breast Cancer Program offers patients personalized treatment and the most recent research data available. At CTCA, we fight breast cancer with advanced medical treatments that help patients experience a better quality of life. Learn more about our breast cancer treatment.
Breast Cancer Research Program, Congressionally Directed Medical Research Programs. Vision - To end breast cancer by funding innovative, high- impact research through a partnership of scientists and consumers. The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high- impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations. Click on Image to View Program Booklet. The Breast Cancer Landscape (2.
This overview describes what is currently known about the most pertinent topics that are consistent with the BCRP's vision of ending breast cancer. Applicants are strongly urged to read and consider The Breast Cancer Landscape before preparing their applications. BCRP Overarching Challenges. Considering the current breast cancer landscape and the BCRP's vision to end breast cancer, the BCRP seeks applications that address the following overarching challenges: Prevent breast cancer (primary prevention) Identify determinants of breast cancer initiation, risk, or susceptibility Distinguish deadly from indolent breast cancers Conquer the problems of overdiagnosis and overtreatment Identify what drives breast cancer growth; determine how to stop it Identify why some breast cancers become metastatic Determine why/how breast cancer cells lie dormant for years and then re- emerge (recurrence); determine how to prevent recurrence Revolutionize treatment regimens by replacing them with ones that are more effective and less toxic.
Eliminate the mortality associated with metastatic breast cancer.